Cure Thalassemia
Founded in 2011 and headquartered in Telangana, India.
2011 | Hyderabad, Telangana (India) | Active
Cure Thalassemia Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth -1.73%
- Total Assets -0.27%
About Cure Thalassemia
Cure Thalassemia (CT) is a Private Not For Profit Company incorporated in India on 21 July 2011 and has a history of 13 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Agarwal and Chandrakant Agrawal serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100TG2011NPL075631
- Company No.
075631
- Company Classification
Private Not For Profit Company
- Incorporation Date
21 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Cure Thalassemia
Explore comprehensive data for Cure Thalassemia, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Cure Thalassemia?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrakant Agrawal  | Director | 21-Jul-2011 | Current |
| Mahesh Agarwal | Director | 21-Jul-2011 | Current |
Financial Performance of Cure Thalassemia.
Cure Thalassemia, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cure Thalassemia?
In 2017, Cure Thalassemia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Swastik Siddhatva Private LimitedMahesh Agarwal is a mutual person
- Sri Navdurga Billets Private Limited
Mahesh Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cure Thalassemia?
Unlock and access historical data on people associated with Cure Thalassemia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Thalassemia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Thalassemia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Cure Thalassemia
Recent activity within the organization
- Annual General Meeting
Cure Thalassemia last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Cure Thalassemia has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Mahesh Kumar Agarwal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 13 years 9 months .
- Director Appointment
Chandrakant Agrawal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 13 years 9 months .
- Company Incorporation
Cure Thalassemia was registered on 21 Jul 2011 with Roc Hyderabad & aged 13 years 9 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Cure Thalassemia?
Cure Thalassemia was incorporated on 21 Jul 2011.
What is authorized share capital and paid-up capital of Cure Thalassemia?
The authorized share capital of Cure Thalassemia is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Cure Thalassemia?
Currently 2 directors are associated with Cure Thalassemia.
- Mahesh Kumar Agarwal
- Chandrakant Agrawal
What is the registered address of Cure Thalassemia?
As per Ministry of Corporate Affairs (Mca), the registered address of Cure Thalassemia is 21-1-686, Rikab Gunj India, Hyderabad, Telangana, 500002.
What is the corporate identification number (CIN) and company number of Cure Thalassemia?
The corporate identification number (CIN) of Cure Thalassemia is U85100TG2011NPL075631 and the company number is 075631 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Cure Thalassemia, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Cure Thalassemia has experienced an downturn of -1.73%.
When was the last Balance Sheet of Cure Thalassemia filed with the ROC?
The most recent Balance Sheet for Cure Thalassemia was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records